Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Molecular Partners AG
DescriptionDesigned ankyrin repeat protein (DARPin) that inhibits platelet derived growth factor B (PDGFB; PDF2) and vascular endothelial growth factor A (VEGF-A)
Molecular Target Platelet derived growth factor B (PDGFB) (PDGF2) ; Vascular endothelial growth factor A (VEGF-A)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat wet age-related macular degeneration (AMD)
Regulatory Designation
PartnerAllergan plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today